[go: up one dir, main page]

BR0013958A - Dieta de elevado teor de lipìdios - Google Patents

Dieta de elevado teor de lipìdios

Info

Publication number
BR0013958A
BR0013958A BR0013958-0A BR0013958A BR0013958A BR 0013958 A BR0013958 A BR 0013958A BR 0013958 A BR0013958 A BR 0013958A BR 0013958 A BR0013958 A BR 0013958A
Authority
BR
Brazil
Prior art keywords
composition
high lipid
medicament
lipid diet
nutritional product
Prior art date
Application number
BR0013958-0A
Other languages
English (en)
Inventor
Marco Turini
Claudia Roessle
Denis Breuille
Gayle Crozier-Willi
Paul-Andre Finot
Myriam Richelle
Guy Dutot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238988&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0013958(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0013958A publication Critical patent/BR0013958A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção: "DIETA DE ELEVADO TEOR DE LIPìDIOS". é descrita uma composição para utilização como um medicamento ou produto nutricional que compreende pelo menos um lipídio em que o lipídio proporciona mais de 35% da energia total da composição. Uma concretização preferida compreende uma relação de ácidos graxos n-6/n-3 de cerca de 2/1 a 7/1. Adicionalmente, são descritos um processo de preparação da composição; utilização da composição na fabricação de um medicamento ou produto nutricional; e a um processo de tratamento ou prevenção de sepse ou choque inflamatório que compreende a administração de uma quantidade efetiva da composição.
BR0013958-0A 1999-09-13 2000-09-07 Dieta de elevado teor de lipìdios BR0013958A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99118173A EP1090636A1 (en) 1999-09-13 1999-09-13 High lipid diet
PCT/EP2000/008731 WO2001019356A2 (en) 1999-09-13 2000-09-07 High lipid diet

Publications (1)

Publication Number Publication Date
BR0013958A true BR0013958A (pt) 2002-05-14

Family

ID=8238988

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013958-0A BR0013958A (pt) 1999-09-13 2000-09-07 Dieta de elevado teor de lipìdios

Country Status (13)

Country Link
US (2) US6995189B1 (pt)
EP (2) EP1090636A1 (pt)
CN (1) CN1222284C (pt)
AT (1) ATE258792T1 (pt)
AU (1) AU6843000A (pt)
BR (1) BR0013958A (pt)
CA (1) CA2384859C (pt)
DE (1) DE60008127T2 (pt)
ES (1) ES2213036T3 (pt)
HK (1) HK1052298B (pt)
MX (1) MXPA02002728A (pt)
PT (1) PT1216041E (pt)
WO (1) WO2001019356A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009704A2 (en) * 2001-07-27 2003-02-06 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
DE602004005821T2 (de) * 2003-02-05 2008-01-10 N.V. Nutricia Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
US20080108548A1 (en) * 2004-11-12 2008-05-08 N.V. Nutricia Food Composition For Rapidly Attenuating Inflammatory Responses
US8821947B2 (en) * 2006-06-01 2014-09-02 Howard W. Selby, III Cholesterol-reducing diet
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
WO2008046865A2 (en) * 2006-10-19 2008-04-24 Nestec S.A. Long-term feed - elderly
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
CA2692309C (en) 2007-06-26 2016-08-16 N.V. Nutricia Improving memory in subjects with mini-mental state examination of 24-26
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
ES2697149T3 (es) 2007-12-20 2019-01-22 Nutricia Nv Producto líquido que contiene nucleótidos/nucleósidos
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
TR201808471T4 (tr) * 2010-07-05 2018-07-23 Beth Israel Deaconess Medical Ct Inc Sn-2-monoaçilgliseroller ve lipid malabsorpsiyonu.
WO2012138212A1 (en) 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
CN104026591A (zh) * 2014-04-04 2014-09-10 上海英莱腾医药研究有限公司 一种含中链甘油三酯的多功能蛋白食品组合物
WO2016013617A1 (ja) * 2014-07-23 2016-01-28 一般財団法人糧食研究会 脳機能改善剤、及び認知機能障害の予防または治療剤
US11162708B2 (en) * 2015-11-16 2021-11-02 Genie Enterprise Ltd. Apparatus for rapid heating of liquids
US20180185317A1 (en) * 2016-12-29 2018-07-05 Immodulon Therapeutics Limited Immunotherapeutic agent
CN108402467A (zh) * 2018-03-01 2018-08-17 苏州恒瑞健康科技有限公司 一种提高肿瘤患者营养需求的组合物及其应用、用于提高外源性脂肪利用率的食品及药品
EP3820463A1 (en) * 2018-07-10 2021-05-19 Société des Produits Nestlé S.A. Mct formulations for increasing ketone exposure and methods of making and using such formulations
CN108703180A (zh) * 2018-08-29 2018-10-26 西安瑞仁生物技术有限公司 一种高纤、低碳、高脂的生酮饼干及其制备方法
AU2020284169A1 (en) * 2019-05-31 2021-10-28 Societe Des Produits Nestle Sa MCT-based nutrition blend for providing health benefits in animals

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055446A (en) 1988-10-21 1991-10-08 University Of Cincinnati Method to improve survival of patients during sepsis by diet composition
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US5723446A (en) * 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5574065A (en) * 1994-04-21 1996-11-12 Clintec Nutrition Co. Method and composition for normalizing injury response
US5733884A (en) 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US6008248A (en) * 1995-11-28 1999-12-28 B. Braun Melsungen Ag Hydrolysis-optimized lipid emulsions and use thereof
EP0852913A1 (en) * 1997-01-14 1998-07-15 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis

Also Published As

Publication number Publication date
HK1052298B (zh) 2006-07-07
EP1216041B1 (en) 2004-02-04
AU6843000A (en) 2001-04-17
CA2384859C (en) 2007-07-03
CN1390125A (zh) 2003-01-08
PT1216041E (pt) 2004-05-31
US20050281864A1 (en) 2005-12-22
WO2001019356A2 (en) 2001-03-22
ES2213036T3 (es) 2004-08-16
ATE258792T1 (de) 2004-02-15
HK1052298A1 (en) 2003-09-11
EP1216041A2 (en) 2002-06-26
WO2001019356A3 (en) 2001-05-17
EP1090636A1 (en) 2001-04-11
US6995189B1 (en) 2006-02-07
MXPA02002728A (es) 2002-08-30
DE60008127T2 (de) 2004-09-09
CA2384859A1 (en) 2001-03-22
CN1222284C (zh) 2005-10-12
DE60008127D1 (de) 2004-03-11
US7691906B2 (en) 2010-04-06

Similar Documents

Publication Publication Date Title
BR0013958A (pt) Dieta de elevado teor de lipìdios
NZ516101A (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
FR2635263B1 (pt)
EP1832181A3 (en) Microbial oil mixtures and uses thereof
MXPA01006455A (es) Composiciones para el cuidado de la piel que contienen acido linoleico cis-9, trnas-11.
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
MY109928A (en) Fatty acid treatment
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
DE69935995D1 (de) Polyungesättigen fettsäuren nährungsergänzung
DK1411960T3 (da) Födevareprodukt af beriget risklid til fremme af hjerte-kar-sundhed
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
IT1187687B (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
ATE81453T1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DK0631772T3 (da) Retinoidholdig sammensætning
EP1637137A3 (en) Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
ATE142491T1 (de) Mittel zur behandlung des atopischen ekzems und anderen entzündlichen hautkrankheiten
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
TW325404B (en) Pharmaceutical composition for the safe administration of fatty acids the invention relates to a pharmaceutical composition for the safe administration of fatty acids which is useful in the treatment of cancer, viral infections and other disorders.
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
HU913009D0 (en) Method for producing inhibitors of calcium ingestion
ATE91079T1 (de) Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.